Free Trial

6,716 Shares in Danaher Corporation $DHR Purchased by Davidson Trust Co.

Danaher logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Davidson Trust Co. purchased 6,716 Danaher shares during the third quarter, valued at approximately $1.49 million. Institutional investors collectively own 79.05% of Danaher’s outstanding stock.
  • Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $235.23; several firms recently raised their targets to $250–$255.
  • Danaher exceeded quarterly expectations, reporting $1.94 in earnings per share and $6.26 billion in revenue, while declaring a quarterly dividend of $0.40 per share.
  • Interested in Danaher? Here are five stocks we like better.

Davidson Trust Co. purchased a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 6,716 shares of the conglomerate's stock, valued at approximately $1,488,000.

A number of other hedge funds have also made changes to their positions in DHR. BlackRock Inc. acquired a new stake in Danaher in the 2nd quarter valued at $10,492,520,000. Jupiter Topco LLC acquired a new position in shares of Danaher during the second quarter worth about $1,456,317,000. Generation Investment Management LLP purchased a new stake in shares of Danaher in the second quarter worth about $1,287,949,000. Bank of America Corp DE acquired a new stake in shares of Danaher in the second quarter valued at about $993,846,000. Finally, Legal & General Group Plc purchased a new stake in shares of Danaher during the 2nd quarter valued at about $801,056,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of analyst reports. Weiss Ratings upgraded Danaher from a "hold (c-)" rating to a "hold (c)" rating in a report on Wednesday, September 16th. Stifel Nicolaus reduced their target price on shares of Danaher from $260.00 to $220.00 and set a "buy" rating on the stock in a research report on Wednesday, July 22nd. Guggenheim upped their target price on shares of Danaher from $200.00 to $250.00 and gave the company a "buy" rating in a research note on Thursday, October 1st. Barclays raised their target price on Danaher from $230.00 to $255.00 and gave the company an "overweight" rating in a research note on Wednesday. Finally, Royal Bank Of Canada upped their price target on shares of Danaher from $215.00 to $250.00 and gave the company an "outperform" rating in a report on Monday. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $235.23.

Check Out Our Latest Analysis on Danaher

Danaher Stock Performance

Shares of NYSE DHR opened at $220.15 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The firm's 50-day moving average price is $211.38 and its two-hundred day moving average price is $194.62. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The stock has a market capitalization of $154.76 billion, a P/E ratio of 39.10, a P/E/G ratio of 2.71 and a beta of 0.76.

Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business's revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.77 earnings per share. As a group, sell-side analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher's dividend payout ratio (DPR) is currently 28.42%.

Danaher Company Profile

(Free Report)

Danaher Corporation NYSE: DHR is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines